Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Blast Crisis 1

Interventions

fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Cyclophosphamide 2Antilymphocyte Serum 2sargramostim 1danusertib 1Tacrolimus 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Methylprednisolone 1Methotrexate 1Melphalan 1Levofloxacin 1Ketamine 1Flow Cytometry 1Filgrastim 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cefepime 1Carboplatin 1Busulfan 1Arsenic Trioxide 1Analgesia 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Blast Crisis × danusertib × Clear all
NCT00335868 2013-12-18

PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
16 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡